JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263280

Human NME6 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

NME6 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon3 and 1 bp insertion in exon3 and 8 bp deletion in exon3.

View Alternative Names

IPIA-alpha, Inhibitor of p53-induced apoptosis-alpha, NDK6_HUMAN, NDP kinase 6, Nucleoside diphosphate kinase 6, OTTHUMP00000164810, OTTHUMP00000210736, OTTHUMP00000210737, OTTHUMP00000210738, OTTHUMP00000210741, OTTHUMP00000210742, OTTHUMP00000210744, OTTHUMP00000210745, nm23-H6

3 Images
Sanger Sequencing - Human NME6 knockout HEK-293T cell lysate (AB263280)
  • Sanger seq

Unknown

Sanger Sequencing - Human NME6 knockout HEK-293T cell lysate (AB263280)

Allele-3 : 1 bp insertion in exon3

Sanger Sequencing - Human NME6 knockout HEK-293T cell lysate (AB263280)
  • Sanger seq

Unknown

Sanger Sequencing - Human NME6 knockout HEK-293T cell lysate (AB263280)

Allele-1 : 8 bp deletion in exon3

Sanger Sequencing - Human NME6 knockout HEK-293T cell lysate (AB263280)
  • Sanger seq

Unknown

Sanger Sequencing - Human NME6 knockout HEK-293T cell lysate (AB263280)

Allele-2 : 1 bp deletion in exon3

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon3 and 1 bp insertion in exon3 and 8 bp deletion in exon3.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263280-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human NME6 knockout HEK293T cell lysate", "number":"AB263280-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB263280-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
NME6
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

NME6 also known as NM23-H6 or NDP kinase H6 is an enzyme that plays a role as a nucleoside diphosphate kinase. It weighs approximately 19 kDa and is part of the NME/NM23 nucleoside diphosphate kinase gene family. NME6 appears in various tissues with notable expression in the heart and skeletal muscle indicating its importance in tissues with high energy demands.
Biological function summary

NME6 functions in regulating the levels of nucleoside triphosphates within cells. The enzyme does not act alone; it associates as part of a larger complex where its activity supplements cellular energy metabolism. This involvement in energy conversion underlines its broader role in maintaining the balance of ATP and GTP concentrations which are essential for numerous cellular processes including signal transduction and cell proliferation.

Pathways

The enzyme NME6 integrates into ATP synthesis and metabolism pathways. It holds a relationship with the ATP citrate lyase pathway facilitating the interplay of energy production and consumption. Through this connection NME6 interacts with proteins such as NME1 and NME2 which also participate in maintaining cellular energetic homeostasis.

Alterations in the NME6 function have associations with mitochondrial disorders particularly those impacting tissues with high energetic needs. The enzyme also relates to cardiovascular diseases due to its expression in the cardiac muscle. Defective NME6 expression or function might cause disruptions in energy homeostasis leading to disease states. Additionally through these diseases NME6 potentially connects to other proteins involved in energy metabolism like ATP synthase.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com